Definitive Contract 75F40119C10057

This contract was awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Digital Infuzion, Inc., a minority-owned, for-profit Subchapter S corporation that provides software and healthcare IT services. The contract, valued at $730,303.96, was awarded under a Broad Agency Announcement (BAA) entitled "Integrating EHR RWD for FDA Regulated Submission and Clinical Research." The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and the period of performance was from September 16, 2019 to September 15, 2021. Digital Infuzion has previously held prime contracts with other HHS agencies, including the National Institutes of Health, the Food and Drug Administration, and the Centers for Medicare and Medicaid Services, providing IT services and solutions in support of clinical research management systems, data coordination centers, and translational sciences databases.